| Amyloidosis |
1 |
1 |
| Cardiomyopathy |
0 |
0.56 |
| Heart |
0 |
0.55 |
| Heart Failure (HF) |
0 |
0.45 |
| Transplantation |
0 |
0.44 |
| Cell Transplantation |
0 |
0.39 |
| Biopsy |
0 |
0.33 |
| Florida |
0 |
0.33 |
| Stem Cell Research and Therapy |
0 |
0.29 |
| Arrhythmia |
0 |
0.26 |
| Prognosis |
0 |
0.22 |
| Restrictive Cardiomyopathy (RCM) |
0 |
0.22 |
| Tissue |
0 |
0.22 |
| Cutaneous Lupus Erythematosus |
0 |
0.16 |
| Board Certification |
0 |
0.11 |
| Chemotherapy |
0 |
0.11 |
| Dermatomyositis |
0 |
0.11 |
| Internet |
0 |
0.11 |
| Lipoid Proteinosis |
0 |
0.11 |
| Liver |
0 |
0.11 |
| Lupus |
0 |
0.11 |
| Macroglossia |
0 |
0.11 |
| Osteopathic Medicine |
0 |
0.11 |
| Private Practice |
0 |
0.11 |
| Proteasome Inhibitor |
0 |
0.11 |
| Quality of Life |
0 |
0.11 |
| Skin Lesion |
0 |
0.11 |
| Steroids |
0 |
0.11 |
| Syncope |
0 |
0.11 |
| Otolaryngology |
0 |
0.1 |
| Systemic Lupus Erythematosus |
0 |
0.1 |
| Angina Pectoris |
0 |
0.06 |
| Complementary and Alternative Medicine |
0 |
0.06 |
| Revenue and Practice Management |
0 |
0.06 |